FHIR IG analytics

Resources that use this resource

Resources that this resource uses

Narrative

No narrative content found in resource

Source1

{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113883.3.464.1003.110.11.1154",
  "meta": {
    "versionId": "14",
    "lastUpdated": "2023-12-21T17:43:03.000-05:00",
    "profile": [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueContactDetail": {
        "name": "NCQA PHEMUR Author"
      }
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate": "2025-03-10"
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate": "2021-09-23"
    }
  ],
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1154",
  "identifier": [
    {
      "system": "urn:ietf:rfc:3986",
      "value": "urn:oid:2.16.840.1.113883.3.464.1003.110.11.1154"
    }
  ],
  "version": "20210923",
  "name": "HiBVaccine4DoseSchedule",
  "title": "HiB Vaccine (4 dose schedule)",
  "status": "active",
  "experimental": false,
  "date": "2021-09-23T01:03:11-04:00",
  "publisher": "NCQA PHEMUR",
  "jurisdiction": [
    {
      "coding": [
        {
          "system": "urn:iso:std:iso:3166",
          "code": "US"
        }
      ]
    }
  ],
  "purpose": "(Clinical Focus: The purpose of this value set is to represent concepts for immunizations with 4-dose haemophilus influenzae type b (Hib) vaccines.),(Data Element Scope: This value set may use a model element related to Immunization.),(Inclusion Criteria: Includes concepts that represent a 4-dose haemophilus influenzae type b (Hib) vaccine.),(Exclusion Criteria: No exclusions.)",
  "compose": {
    "include": [
      {
        "system": "http://hl7.org/fhir/sid/cvx",
        "concept": [
          {
            "code": "120",
            "display": "diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV)"
          },
          {
            "code": "146",
            "display": "Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate (Meningococcal Protein Conjugate), and Hepatitis B (Recombinant) Vaccine."
          },
          {
            "code": "148",
            "display": "Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine"
          },
          {
            "code": "48",
            "display": "Haemophilus influenzae type b vaccine, PRP-T conjugate"
          }
        ]
      }
    ]
  },
  "expansion": {
    "identifier": "urn:uuid:e484cb3d-107c-45e3-91fd-c9123abd2c1e",
    "timestamp": "2025-05-23T22:17:05-04:00",
    "total": 4,
    "contains": [
      {
        "system": "http://hl7.org/fhir/sid/cvx",
        "version": "20250502",
        "code": "120",
        "display": "diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV)"
      },
      {
        "system": "http://hl7.org/fhir/sid/cvx",
        "version": "20250502",
        "code": "146",
        "display": "Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate (Meningococcal Protein Conjugate), and Hepatitis B (Recombinant) Vaccine."
      },
      {
        "system": "http://hl7.org/fhir/sid/cvx",
        "version": "20250502",
        "code": "148",
        "display": "Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine"
      },
      {
        "system": "http://hl7.org/fhir/sid/cvx",
        "version": "20250502",
        "code": "48",
        "display": "Haemophilus influenzae type b vaccine, PRP-T conjugate"
      }
    ]
  }
}